Loading the map…
Research and experimental development on biotechnology · Newport
Human Health Technologies
Human Health Technologies Ltd
Private limited company registered in Newport, classed under “Research and experimental development on biotechnology”.
Headline figures
FY to Dec 2024 · Company only
Turnover
For subscribers
Profit after tax
—
Not filed: small-company exemption
Net assets
For subscribers
Cash
For subscribers
Employees
For subscribers
Retained reserves
For subscribers
What the numbers say
3 findings from the figures, in plain English
Written by rules from the figures on this page. Not a forecast or a credit opinion.
History
| £ | 2019 | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Profit after tax | — | ||||
| Turnover | |||||
| Net assets | |||||
| Cash | |||||
| Employees | |||||
| Retained reserves |
Every figure for all 5 years
“—” means we did not find the figure in a source; it is never filled with an estimate.
Balance sheet and ratios
From the filed balance sheets · £
| Balance sheet | 2020 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Fixed assets | ||||
| Current assets | ||||
| of which debtors | ||||
| of which cash | ||||
| Creditors due within a year | ||||
| Net current assets | ||||
| Net assets | ||||
| Ratios | ||||
| Current ratioCurrent assets for every £1 owed within a year | ||||
| Cash ratioCash for every £1 owed within a year | ||||
| Creditors to assetsEverything owed to creditors as a share of fixed plus current assets | ||||
7 balance-sheet lines and 3 ratios, every year
A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.
Timeline
Checked 2026-10-26
- DirectorsAppointment of Mr Michel Jean Quazza as a director on 8 July 2026
- DirectorsTermination of appointment of Michel Jean Quazza as a director on 8 July 2026
- AccountsTotal exemption full accounts made up to 31 December 2024
- FilingResolutions (and 3 more like it since 19 April 2015)
- FilingMemorandum and Articles of Association
- SharesStatement of capital following an allotment of shares on 29 August 2024 · GBP 5,327,161.5 (and 28 more like it since 29 January 2015)
- DirectorsAppointment of Mr Mark Patrick O'shea as a director on 29 August 2024
- DirectorsAppointment of Mr Michel Jean Quazza as a director on 29 August 2024
- AccountsTotal exemption full accounts made up to 31 December 2023
- AddressRegistered office address changed from Abacus House Caxton Place Pentwyn Cardiff CF23 8HA Wales to Kilsby Williams Hazell Drive Newport NP10 8FY on 24 July 2023
- AccountsTotal exemption full accounts made up to 31 December 2022
- AccountsTotal exemption full accounts made up to 31 December 2021
25 earlier
- AccountsUnaudited abridged accounts made up to 31 December 2020
- OwnershipCessation of Chris Christiansson as a person with significant control on 30 July 2021
- DirectorsTermination of appointment of Chris Christiansson as a director on 30 July 2021
- DirectorsTermination of appointment of Chris Christiansson as a secretary on 30 July 2021
- DirectorsAppointment of Mr Jean-Claude Martinez as a director on 16 March 2021
- AccountsUnaudited abridged accounts made up to 31 December 2019
- AccountsTotal exemption full accounts made up to 31 December 2018
- AddressRegister inspection address has been changed (and 3 more like it since 4 February 2015)
- DirectorsDirector's details changed for Mr Douglas John Lee on 5 August 2019
- AddressRegistered office address changed from C/O City & Westminster Corporate Finance Llp 50 Jermyn St London SW1Y 6LX England to Abacus House Caxton Place Pentwyn Cardiff CF23 8HA on…
- OwnershipNotification of Robert John Davies as a person with significant control on 31 January 2018
- OwnershipChange of details for Mr Chris Christiansson as a person with significant control on 31 January 2018
- OwnershipNotification of Chris Christiansson as a person with significant control on 6 April 2016
- AccountsTotal exemption full accounts made up to 31 December 2017
- ChargesRegistration of charge 091209460002, created on 29 March 2018
- ChargesRegistration of charge 091209460001, created on 29 March 2018
- DirectorsAppointment of Mr Douglas John Lee as a director on 29 March 2018
- DirectorsAppointment of Mr David Alan Whiteley as a director on 29 March 2018
- AccountsPrevious accounting period extended from 31 July 2017 to 31 December 2017
- DirectorsTermination of appointment of Daryl Cumberland as a director on 12 April 2017
- AccountsTotal exemption small company accounts made up to 31 July 2016
- DirectorsAppointment of Mr Daryl Cumberland as a director on 6 March 2017
- AccountsTotal exemption small company accounts made up to 31 July 2015
- AddressRegister(s) moved to registered inspection location (and 1 more like it since 4 February 2015)
- NameCertificate of change of name
- Accounts
From the Companies House filing history. Routine confirmation statements are left out, and a run of the same filing is shown once.
Questions people ask
›What does Human Health Technologies do?
Private limited company registered in Newport, classed under “Research and experimental development on biotechnology”.
›How much turnover does Human Health Technologies make?
Answered in the full report
›Is Human Health Technologies profitable?
Human Health Technologies's profit isn't public: small companies may file without a profit and loss account.
›How many people work at Human Health Technologies?
Answered in the full report
›Who runs and owns Human Health Technologies?
Its directors are Douglas John Lee, Jean-Claude Martinez, Mark Patrick O'Shea, Michel Jean Quazza, David Alan Whiteley. Its owners are shown to subscribers.
›Where is Human Health Technologies based?
Its registered office is Kilsby Williams, Hazell Drive, Newport, NP10 8FY, in Newport.
›When was Human Health Technologies founded?
Human Health Technologies Ltd was incorporated on 8 July 2014.
›Is Human Health Technologies still trading?
The register lists Human Health Technologies Ltd as active.